Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication

Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication

Diabetic muscle infarction (DMI) is a rare complication of poorly controlled type 1 and type 2 diabetes seen mostly in those who have already experienced microvascular complications. Currently, the incidence and prevalence of DMI are difficult to conclude, and there is no clear algorithm or standard...

Full description

Bibliographic Details
Main Authors: Roopam Jariwal, Nadia Raza, Catherine Cadang, Syed Rahman, David Contreras, Ramanjeet Sidhu, Janpreet Bhandohal
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2021/5555051
id doaj-ea7fa69fa68c4838a86f599726de190b
record_format Article
spelling doaj-ea7fa69fa68c4838a86f599726de190b2021-07-26T00:34:36ZengHindawi LimitedCase Reports in Medicine1687-96352021-01-01202110.1155/2021/5555051Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter MedicationRoopam Jariwal0Nadia Raza1Catherine Cadang2Syed Rahman3David Contreras4Ramanjeet Sidhu5Janpreet Bhandohal6UCLA-Kern Medical CenterUCLA-Kern Medical CenterAmerican University School of MedicineAmerican University School of MedicineUCLA-Kern Medical CenterUCLA-Kern Medical CenterUCLA-Kern Medical CenterDiabetic muscle infarction (DMI) is a rare complication of poorly controlled type 1 and type 2 diabetes seen mostly in those who have already experienced microvascular complications. Currently, the incidence and prevalence of DMI are difficult to conclude, and there is no clear algorithm or standard of care in managing this condition. Pathogenesis of the microangiopathy of DMI remains unclear. A major finding in this investigation of DMI emphasizes that, within 2–17 weeks, patients who initiate low-dose acetylsalicylic acid, bed rest, and close outpatient follow-up see significant size reduction of lower extremity mass and complete resolution of pain without being subjected to invasive muscle biopsy.http://dx.doi.org/10.1155/2021/5555051
collection DOAJ
language English
format Article
sources DOAJ
author Roopam Jariwal
Nadia Raza
Catherine Cadang
Syed Rahman
David Contreras
Ramanjeet Sidhu
Janpreet Bhandohal
spellingShingle Roopam Jariwal
Nadia Raza
Catherine Cadang
Syed Rahman
David Contreras
Ramanjeet Sidhu
Janpreet Bhandohal
Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication
Case Reports in Medicine
author_facet Roopam Jariwal
Nadia Raza
Catherine Cadang
Syed Rahman
David Contreras
Ramanjeet Sidhu
Janpreet Bhandohal
author_sort Roopam Jariwal
title Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication
title_short Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication
title_full Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication
title_fullStr Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication
title_full_unstemmed Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication
title_sort diabetic muscle infarction: resolution of rare microangiopathy with over-the-counter medication
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9635
publishDate 2021-01-01
description Diabetic muscle infarction (DMI) is a rare complication of poorly controlled type 1 and type 2 diabetes seen mostly in those who have already experienced microvascular complications. Currently, the incidence and prevalence of DMI are difficult to conclude, and there is no clear algorithm or standard of care in managing this condition. Pathogenesis of the microangiopathy of DMI remains unclear. A major finding in this investigation of DMI emphasizes that, within 2–17 weeks, patients who initiate low-dose acetylsalicylic acid, bed rest, and close outpatient follow-up see significant size reduction of lower extremity mass and complete resolution of pain without being subjected to invasive muscle biopsy.
url http://dx.doi.org/10.1155/2021/5555051
work_keys_str_mv AT roopamjariwal diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
AT nadiaraza diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
AT catherinecadang diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
AT syedrahman diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
AT davidcontreras diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
AT ramanjeetsidhu diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
AT janpreetbhandohal diabeticmuscleinfarctionresolutionofraremicroangiopathywithoverthecountermedication
_version_ 1721282487261331456

Similar Items